This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2dg9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2dg9.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2dg9.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2dg9| PDB=2dg9 | SCENE= }}
{{STRUCTURE_2dg9| PDB=2dg9 | SCENE= }}
-
'''FK506-binding protein mutant WL59 complexed with Rapamycin'''
+
===FK506-binding protein mutant WL59 complexed with Rapamycin===
-
==Overview==
+
<!--
-
Tryptophan 59 forms the seat of the hydrophobic ligand-binding site in the small immunophilin FKBP12. Mutating this residue to phenylalanine or leucine stabilizes the protein by 2.72 and 2.35 kcal mol(-1), respectively. Here we report the stability data and 1.7 A resolution crystal structures of both mutant proteins, complexed with the immunosuppressant rapamycin. Both structures show a relatively large response to mutation involving a helical bulge at the mutation site and the loss of a hydrogen bond that anchors a nearby loop. The increased stability of the mutants is probably due to a combination of improved packing and an entropic gain at the mutation site. The structures are almost identical to that of wild-type FKBP12.6, an isoform of FKBP12 that differs by 18 residues, including Trp59, in its sequence. Therefore, the structural difference between the two isoforms can be attributed almost entirely to the identity of residue 59. It is likely that in FKBP12-ligand complexes Trp59 provides added binding energy at the active site at the expense of protein stability, a characteristic common to other proteins. FKBP12 associates with the ryanodine receptor in skeletal muscle (RyR1), while FKBP12.6 selectively binds the ryanodine receptor in cardiac muscle (RyR2). The structural response to mutation suggests that residue 59 contributes to the specificity of binding between FKBP12 isoforms and ryanodine receptors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_12600203}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 12600203 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_12600203}}
==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Isomerase]]
[[Category: Isomerase]]
[[Category: Rotamase]]
[[Category: Rotamase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 00:21:45 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 13:27:44 2008''

Revision as of 10:27, 27 July 2008

Image:2dg9.png

Template:STRUCTURE 2dg9

FK506-binding protein mutant WL59 complexed with Rapamycin

Template:ABSTRACT PUBMED 12600203

About this Structure

2DG9 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Energetic and structural analysis of the role of tryptophan 59 in FKBP12., Fulton KF, Jackson SE, Buckle AM, Biochemistry. 2003 Mar 4;42(8):2364-72. PMID:12600203

Page seeded by OCA on Sun Jul 27 13:27:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2dg9"
Personal tools